Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis

Background Primary sclerosing cholangitis (PSC) is a progressive immune-mediated liver disease, for which no medical therapy has been shown to slow disease progression. However, the horizon for new therapies is encouraging, with several innovative clinical trials in progress. Despite these advanceme...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Martine Walmsley, Vipul Jairath, Christoph Schramm, Michael Trauner, Christopher Ma, Gideon Hirschfield, Palak J Trivedi, Nasir Hussain, Olalekan Lee Aiyegbusi, Mette Vesterhus, Kris Kowdley, Cyriel Ponsioen, Annika Bergquist, Paula Hanford, Cynthia Levy, David Assis, Christopher Bowlus
Format: Artykuł
Język:English
Wydane: BMJ Publishing Group 2024-06-01
Seria:BMJ Open
Dostęp online:https://bmjopen.bmj.com/content/14/6/e080143.full